|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| A61K 31/415 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 2125786 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07858987.6 |
| Date of filing the European patent application | 2007-12-03 | |
| (97) | Date of publication of the European application | 2009-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2011-03-16 |
| (46) | Date of publication of the claims translation | 2011-07-25 |
| (86) | Number | PCT/IB2007/003819 |
| Date | 2007-12-03 |
| (87) | Number | WO 2008/084299 |
| Date | 2008-07-17 |
| (30) | Number | Date | Country code |
| 871260 P | 2006-12-21 | US |
| (72) |
VORHOEST, Patrick, Robert, US
PROULX, Caroline, US
|
| (73) |
Pfizer Products Inc.,
Eastern Point Road, Groton, CT 06340,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 2-((4-(1-Metil-4-(piridin-4-il)-1H-pirazol-3-il)-fenoksi)metil)chinolino sukcinato druska |
| SUCCINATE SALT OF 2-((4-(1-METHYL-4-(PYRIDIN-4-YL)-1H-PYRAZOL-3-YL) PHENOXY)METHYL)QUINOLINE |
| Payment date | Validity (years) | Amount | |
| 2017-11-20 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-12-03 |